Руяткина Л. А., Бондарева З. Г., Антонов А. Р. ОКИСЛИТЕЛЬНЫЙ МЕТАБОЛИЗМ ПОЛИМОРФНОЯДЕРНЫХ ЛЕЙКОЦИТОВ ПРИ ФОРМИРОВАНИИ СЕРДЕЧНО-СОСУДИСТОГО МЕТАБОЛИЧЕСКОГО СИНДРОМА У МУЖЧИН. Российский кардиологический журнал. 2005;(4):36-41.
1. Руяткина Л.А., Галенок В.А. Патогенетические особенности нарушений углеводного обмена при гипертонической болезни.//Диабетография, 1996. -№6. С. 19-23.
2. Nunes J.S., Correia L.G., Соггеа J.N. No title available.//Acta Med.Port. -2000. -V.13. -N.4. -P. 203-210.
3. Маянский Д.Н. Хроническое воспаление. М.: Медицина, 1991. -271 с.
4. Chen S.S., Monteiro H.P., Deucher G.R et al. Functional activity of blood polymorphonuclear leucocyte as an oxidative stress biomarker in human subjects//Free Radic. Biol. Med. -1998. -V.24. -N.9. -P. 1411-1418.
5. Kopprasch S., Graessler J., Seibt R. et al. Leucocytes responsiveness to substances that activate the respiratory burst is not altered in borderline and essential hypertension//J.Hum.Hypertens. -1996. -V.10. -N.2. -P. 69-76.
6. Kristal В., Shurtz-Swirski R., Chezar J. et al. Participation of peripheral of polymorphonuclear leucocytes in oxidative stress and inflammation in patients with essential hypertension//Am. J. Hypertens. -1998. -V.11. -N.8 pt.l. -P. 921-928.
7. Delamaire M., Maugendre D., Moreno M. et al. Impaired leucocyte in diabetes patients//Diabet. Med. -1997. -V. 14. -N.l. -P. 29-34
8. Ohmori M., Harada K., Kitoh Y et al. The functions of circulatory polymorphonuclear leucocyte in diabetes patients with and without diabetic triopathy//Life Sci. -2000. -V.66. -N.19. -P. 1861-1870.
9. Wierusz-Wysocka В., Kubicka M., Wykretowicz A. et al. Superoxide anion production and adhesiveness of neutrophils in obese patients//Pol.Arch.Med.Wewn. -Pol.Arch.Med.Wewn.->1989. -V.82. -N. 2-3. -P. 980104. 18.
10. Yasuda M., Shimizu S., Tokuyama S. et al. A novel effect of polymorphonuclear leucocytes in the facilitation of angiogenesis//Life Sci. -2000. -V.66. -P. 2113-2121.
11. Ide Т., Tsutsui H., Ohashi N. et al. Greater oxidative stress in healthy young men compared with premenopausal women.//Arterioscler. Thromb. -2002; V.22. -P. 438-42.
12. Руяткина Л.А., Галенок В.А., Бондарева З.Г. Анализ информативности показателей инсулинглюкозного гомеостаза у больных с метаболическим синдромом X.//Тер.арх. -2002. -№ 4. -С. 63-65.
13. Климов Ф.Н., Никульчева Н.Г. Обмен липидов и липопротеидов и его нарушения. -СПб: Питер Ком, 1999. -512 с.
14. Das R.K., Muddeshwar M.G. Alteration in the activities of the membrane-integrated enzymes of polymorphonuclear leucocyte in obesity//Indian Heart J. -1997. -V.49. -N.5. -P. 521-524.
15. Aleksandrovski Y.A. Molecular mechanisms of diabetic complications//Biochemistry. -1998. -V.63. -N.11 Biochemistry.-1998.-V.63.-N.il>. -P. 1249-1257.
16. Targher G., Seidell J.C., Tonoli M. et al. The white blood cell count: its relationship to plasma insulin and other cardiovascular risl factors in healthy male individuals//J. Intern.Med. -1996. -V. 239. -N5. -P. 435-441.
17. Zimmet P., Boyko E.J., Collier G.R. et al. Etiology of the metabolic syndrom: potential role of insulin resistant, and other players//Ann. N.Y.Acad.Sci. -1999. -V. 892. -P. 25-44.
18. Muller-Weland D., Kotzka J., Knebel B. et al. Metabolic syndrome and hypertension: pathophysiology and molecular basis of insulin resistance//Basic Res.Cardio. -1998. -V. 93. -S.2. -P. 131-134.
